10-Q: Aibotics Faces Severe Liquidity Crisis, Going Concern Doubt

Aibotics, Inc. reported a widening net loss and significant working capital deficit for Q2 2025, raising substantial doubt about its ability to continue as a going concern.

Summary

• Aibotics, Inc. incurred a net loss of $1,077,546 for the six months ended June 30, 2025, an increase from $896,617 in the same period of 2024.
• The company generated minimal revenue of $2,183 for the six months ended June 30, 2025, compared to no revenue in the prior year period.
• Operating expenses increased by 19% to $892,226 for the six months ended June 30, 2025, up from $752,282 in 2024.
• As of June 30, 2025, the company had a working capital deficit of $5,151,741, worsening from a deficit of $4,666,666 as of December 31, 2024.
• Cash and cash equivalents increased to $242,179 as of June 30, 2025, from $185,097 at December 31, 2024, primarily due to financing activities.
• Cash flows from operating activities remained negative, using $192,918 for the six months ended June 30, 2025, an increase from $164,229 used in the prior year period.
• All convertible notes payable are currently in default.
• The company's accumulated deficit grew to $11,886,802 as of June 30, 2025.
• Common stock outstanding significantly increased to 191,904,437 shares as of August 19, 2025, up from 39,990,903 shares at December 31, 2024.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, evidenced by a substantial working capital deficit, recurring and increasing net losses, negative operating cash flows, and all convertible debt being in default. The explicit 'going concern' warning indicates a high probability of bankruptcy or significant restructuring that would severely impair shareholder value. While there's minimal revenue, it's not enough to offset the fundamental financial instability.

Positives

• The company generated its first reported revenue of $2,183 for the six months ended June 30, 2025.
• Cash and cash equivalents increased by $57,082 to $242,179 as of June 30, 2025, primarily due to proceeds from financing activities.

Negatives

• Net loss increased to $1,077,546 for the six months ended June 30, 2025, compared to $896,617 for the same period in 2024.
• Operating expenses rose by 19% to $892,226 for the six months ended June 30, 2025.
• The working capital deficit worsened to $5,151,741 as of June 30, 2025.
• Cash used in operating activities increased to $192,918 for the six months ended June 30, 2025.
• All convertible notes payable are in default, indicating significant financial distress and potential for further dilution or legal action.
• The company's accumulated deficit continues to grow, reaching $11,886,802.
• Significant share dilution occurred, with common shares outstanding increasing substantially, which negatively impacts existing shareholder value.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses, negative operating cash flows, and a significant working capital deficit.
• The company is dependent on future debt or equity financing to fund its operations, with no assurance of success in securing additional capital.
• There is no assurance that management's actions will result in profitable operations or the resolution of its liquidity problems.
• All convertible notes payable are in default, which could lead to accelerated repayment demands or further dilutive conversions.
• The company's existence is dependent upon its ability to develop profitable operations, which has not yet been achieved.

Future Outlook

Management expects to continue funding operations primarily through the issuance of debt or equity. The company is actively pursuing additional equity financing through discussions with investment bankers and private investors. However, there is no assurance that these efforts will be successful, or that the company will develop profitable operations or resolve its liquidity problems.

Management Comments

• Management expects the Company to continue to fund its operations primarily through the issuance of debt or equity.
• There can be no assurance that the Company will be successful in its effort to secure additional equity financing.
• The Company's existence is dependent upon management's ability to develop profitable operations.
• No assurance can be given that management's actions will result in profitable operations or the resolution of its liquidity problems.

Industry Context

Aibotics, Inc. is in an early-stage development phase, transitioning to a growth-oriented company focused on applying advanced engineering and design techniques to new products, likely in the AI/robotics sector. Its current financial state, characterized by minimal revenue and significant losses, is typical for early-stage tech companies, but the explicit 'going concern' warning indicates severe financial distress that is not sustainable without substantial capital infusion.

Comparison to Industry Standards

• The company's financial performance, marked by a significant working capital deficit and recurring net losses, falls far below the standards for established companies in the technology or robotics industry.
• For a company aiming to be 'growth-oriented' in advanced engineering, the reported revenue of $2,183 is negligible and indicates a very early stage of commercialization, lagging behind more mature or well-funded competitors in the AI/robotics space.
• The 'going concern' warning is a critical indicator of financial instability, a condition that would typically deter institutional investors and is not comparable to financially healthy industry peers.

Corporate Governance

Related Party Transactions

• A $165,000 note payable to a major shareholder, accruing interest at 1.75% compounded annually, matured on January 30, 2025. As of June 30, 2025, $4,090 in accrued interest was related to this note.
• An Executive Consulting Agreement with CEO Benjamin Kaplan, effective November 17, 2021, provides for an annual base consulting fee of $288,000 ($24,000 monthly).
• As of June 30, 2025, $958,000 in cash compensation was outstanding as accrued expense due to the Aibotics Consulting Agreement with the CEO.
• Accrued expenses from board compensation totaled $190,000 as of June 30, 2025.

Stakeholder Impact

• Shareholders face significant dilution due to the issuance of common stock to settle accrued expenses and convert debt, and potential for further dilution from future equity financing.
• Creditors holding convertible notes are impacted by the default status of all such notes, increasing their risk of non-payment or forced conversion at potentially unfavorable terms.
• Employees and management, including the CEO and board, have significant accrued compensation that has not been paid in cash, indicating cash flow constraints and potential impact on morale or retention.

Next Steps

• Continue efforts to develop the company's business.
• Actively pursue additional equity financing through investment bankers and private investors.
• Adopt ASU 2023-09 for the Annual Report on Form 10-K for the year ending December 31, 2025.
• Adopt ASU 2024-03 for the annual report for the year ended December 31, 2026.

Key Dates

Recommendation

The company is in severe financial distress, evidenced by a substantial working capital deficit, recurring and increasing net losses, negative operating cash flows, and all convertible debt being in default. The explicit 'going concern' warning indicates a high probability of bankruptcy or significant restructuring that would severely impair shareholder value. While there's minimal revenue, it's insufficient to address the fundamental financial instability. The reliance on future dilutive financing and the lack of assurance for profitable operations make this a highly speculative and risky investment, warranting a strong sell recommendation.

Keywords

Aibotics, SEC filing, 10-Q, quarterly report, financial results, net loss, working capital deficit, going concern, convertible debt, share dilution, liquidity, AI, robotics, intellectual property